We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 17

Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine.


Eli Lilly v. Hospira, interlocutory motion regarding further and better affidavit of documents
  • Gowling WLG
  • Canada
  • January 20 2010

In a case of patent infringement, the Case Management Prothonotary had ordered Hospira to produce a further and better Affidavit of Documents pursuant to an earlier motion by the Plaintiffs.


Scott E. Foster
  • Gowling WLG

Beverley Moore
  • Gowling WLG


Richard Palmi
  • Gowling WLG


Lesley Love
  • Gowling WLG